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We have examined the RNAs involved in the heterologous protection of adult mice from otherwise lethal intranasal
infection with mouse-adapted human A/WSN (H1N1) by defective interfering (DI) equine A/equine/Newmarket/7339/79
(H3N8: EQV) influenza virus, as well as the RNAs involved in the protection of WSN- or EQV-infected mice by their
homologous DI viruses. The aim of this study was to describe the types of defective RNAs present in protected mice in order
to guide the design of potentially protective DI RNAs. The interfering and mouse-protecting activity of DI virus was destroyed
by prolonged UV irradiation (iDI virus) demonstrating that protection correlated with an active DI genome, and not viral
antigen. Protected mice were all infected but suffered a lower degree of morbidity than those given iDI virus. The DI EQV
inoculum contained defective segment 1–8 RNAs while DI WSN inoculum contained only defective segment 1–6 RNAs.
However lungs of mice given EQV 1 DI EQV contained only defective segments 1–4 or 1–6 RNAs (mouse-to-mouse variation),
while control mice given EQV or EQV 1 iDI EQV contained few very defective RNAs. Thus prevention of death was the result
of quantitative and/or qualitative differences in defective RNAs administered to the mice. Only defective segments 1–3 RNAs
were isolated from the lungs of mice given WSN 1 DI WSN, confirming the earlier report of Noble and Dimmock (1995). A
detailed analysis showed that most defective RNAs isolated from the lungs of mice protected from a lethal WSN infection
by DI EQV were EQV in origin. Thus, as no infectious EQV was present, these defective RNAs from the DI EQV inoculum must
have been heterologously replicated in mouse lung by WSN. All defective segment 3–6 RNAs isolated were of EQV origin,
indicating that they were replicated by WSN in preference to its own. Defective segments 1 and 2 were a mixture of EQV and
WSN RNAs. Of 17 defective EQV segment 1–3 sequences from mouse lung, all but three differed in their primary central
deletion from 20 defective RNAs isolated from the inoculum. No bias in the break points was evident. A number of minor
deletions of 2 or more nts were also present in defective EQV and WSN RNAs in segments 1 and 2, but none in segment 3.
Their 59, but not 39, breakpoints were heterogeneous, suggesting that defective RNAs were generated during positive strand
synthesis. Two cloned EQV-defective segment 3 RNAs were chimeras containing a 30 nt insert from segment 1. Most
defective RNAs possessed at least 178 nts from the 59 end of vRNA. The amount of 59 sequence present in those RNAs
correlated with the segment of origin, suggesting that this was the minimum required for propagation of viral RNA in mouse
lung and hence possibly for protection also. © 1998 Academic Press
INTRODUCTION
Influenza A virus has a single stranded negative sense
RNA genome consisting of eight separate segments. In
addition virus particles may contain small defective
RNAs that have arisen during multiplication by internal
deletion of genomic segments (Davis et al., 1980). These
are amplified relative to genomic segments and can be
packaged efficiently in place of the genome segments
from which they were derived (Duhaut and McCauley,
1996). At least some of these deleted genomes are de-
fective interfering (DI) RNAs (Huang and Baltimore, 1970)
that have the ability to interfere with the multiplication of
the influenza virus in vitro (von Magnus, 1954; Nayak,
1980; Nayak et al., 1985, 1989) and can protect mice from
influenza A virus infections in vivo (Dimmock, 1996). Re-
cent work has demonstrated that A/equine/Newmarket/
7339/79 (H3N8: EQV) DI virus protected 100% mice
against an otherwise lethal intranasal EQV pneumonia
and a sublethal infection that more closely resembles
human influenza and acted by inhibiting virus multiplica-
tion in the lungs of infected adult mice (Noble and Dim-
mock, 1994). In addition DI EQV protected mice against
the heterologous WSN subtype, suggesting that DI vi-
ruses might eventually be useful in a prophylactic treat-
ment that can circumvent both antigenic drift and anti-
genic shift. In addition WSN-infected mice could be pro-
tected by co-inoculation with DI WSN, although
protection in this instance was due to the prevention of
virus-induced suppression of the control of T cell num-
bers in the lung that would otherwise result in a fatal
lung consolidation (Morgan and Dimmock, 1992). DI
WSN-mediated protection was demonstrated in three1 To whom reprint requests should be addressed.
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different strains of mice (Morgan et al., 1993) with sur-
vival of approximately 80% of otherwise lethally infected
animals (Dimmock et al., 1986; McLain et al., 1992; Mor-
gan and Dimmock, 1992; Morgan et al, 1993).
Studies of defective RNAs that are associated with the
protection of mice from a lethal homologous infection
with WSN showed that certain of the inoculated defective
RNAs were preferentially replicated in the infected
mouse (Noble and Dimmock, 1995). However, this study
was based mainly on RNA size analysis and was limited
because RT-PCR did not detect all genomic segments
equally well and only a small number of defective RNAs
were sequenced. The major study to date on sequences
of defective RNAs generated in chick embryos involved
A/PR/8/34 (H1N1: Jennings et al., 1983), but the stability
of these RNAs on passage and their interfering ability
was not determined.
Here we report on a study of mice infected intranasally
with a lethal dose of WSN (H1N1) or EQV (H3N8) influ-
enza virus that were protected against death by intrana-
sal inoculation with homologous or heterologous DI virus
(WSN 1 DI WSN, EQV 1 DI EQV, or WSN 1 DI EQV). We
compared the defective RNAs present in the inoculum
with those isolated from mice protected from lethal dis-
ease using RT-PCR and segment-specific primers. The
preferential replication of WSN-defective RNAs 1, 2, and
3 in mice inoculated with WSN 1 DI WSN (Noble and
Dimmock, 1995) was confirmed, but there was less se-
lection of defective RNAs of EQV origin in mice inocu-
lated with EQV 1 DI EQV or WSN 1 DI EQV. Although
there were only one or two RT-PCR bands per RNA
segment (200–600 bp), each contained the sequences of
many different defective RNAs. Those sequences in-
volved in the heterologous protection of mice by DI EQV
from a lethal WSN infection have been studied in detail
for the first time. Because there was no infectious EQV
present in the system, defective EQV RNAs could not be
generated de novo, and all defective EQV RNAs isolated
from lung must have been replicated by the heterologous
WSN. This enabled us to distinguish the potentially pro-
tective defective EQV RNAs of the inoculum from the
nonprotective WSN-defective RNAs that are unavoidably
present in the infectious challenge virus. The majority of
defective RNAs isolated from mice inoculated with WSN
1 DI EQV were of EQV origin, and most of these 47 RNA
sequences were unique, with only three occurring in
both mouse lungs and the inoculum. Virtually all RNAs
analysed possessed at least 178 nucleotides of the 59
end of vRNA. EQV-defective RNAs isolated from pro-
tected mice were on average longer than those present
in the inoculum, suggesting that internal sequences may
play a role in protection. It is concluded that virus strain,
segment of origin, and quantity of defective RNA are also
likely to be relevant to the powerful protection that these
RNAs are able to exert against lethal influenza.
RESULTS
DI influenza virus protects mice from a normally
lethal dose of WSN or EQV
The morbidity and mortality associated with a lethal
intranasal dose of WSN (H1N1) and EQV (H3N8) are
shown in Figs. 1A and 1C (WSN) and Fig. 1B (EQV). Mice
FIG. 1. DI WSN (A) and DI EQV (C) both protected mice from a
normally lethal dose of WSN. DI EQV also protected mice from a
normally lethal dose of EQV (B). Five-week-old C3H/He-mg (H-2k) mice
were inoculated intranasally under ether at 22 h with DI virus (f), iDI
virus (M), or PBS (l), and at 0 h with DI virus (f), iDI virus (M), or PBS
(l) containing 10 LD50 of WSN (A and C) or EQV (B) virus. Daily
morbidity and cumulative mortality (%) on Day 20 p.i. are shown. Each
group contained eight mice, two of which were removed on Day 2 (EQV)
or Day 5 (WSN) for lung RNA extraction.
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given WSN developed the first clinical sign at Day 3 or 4
after infection, whereas those given EQV remained
healthy until Day 6. All infected mice lost weight com-
pared with noninfected or mock-infected controls (data
not shown). All mice were protected from the lethal effect
of WSN by intranasal inoculation with either homologous
DI WSN (Fig. 1A) or heterologous DI EQV (Fig. 1C) and
from EQV by inoculation with DI EQV (Fig. 1B). Mice given
DI virus showed either no clinical disease (DI EQV) or
only mild transient clinical signs (DI WSN) in three sep-
arate experiments. Inactivated DI virus (iDI), which had
been given prolonged UV-irradiation to destroy interfer-
ing activity, afforded little protection, indicating that the
majority of the observed protection was mediated by an
active DI genome rather than by stimulation of host
defence responses with virus antigen. These results are
in complete agreement with previous studies by Noble
and Dimmock (1994, 1995).
RT-PCR analysis of defective RNAs present in mouse-
protecting DI EQV and DI WSN inoculum preparations
DI virus inocula given to the mice in the previous section
were analyzed by RT-PCR using primer pairs specific for the
ends of each of the eight genomic segments as described
in Materials and Methods (see also Table 1). Genomic
segments 4–8 (890–1778 nts) were visible in DI EQV (Fig.
FIG. 2. RT-PCR products obtained from RNA extracted from the DI EQV (DI) and iDI EQV (iDI) (A) and the DI WSN (DI) and iDI WSN (iDI)
(B) inocula used in Fig. 1. RNA from the lungs of mice infected with EQV alone (Virus) is shown for comparison. RNA was extracted and amplified
by RT-PCR using terminal 59 and 39 primers. In (A), the primers used were complementary to the first 25 nts of EQV 59 and 39 termini for
all segments, except for the 59 termini of segments 3 and 8 for which UNI2B was used. In (B), the primers used were complementary to
the first 25 nucleotides of the 39 ends of EQV segments 1, 2, 3, 5, 7, and 8, and to the first 20 nts of the 39 ends of WSN segment 4 and 6.
59 primers were complementary to the first 25 nts of EQV segments 1, 2, 5, and 7. The UNI2B primer homologous to all eight segments of
both viruses was used for segments 3, 4, 6, and 8. EQV segment 4 primers were used for the virus control only. The RNA segment number
is indicated at the top of each lane. Genomic length RNAs range from 0.89 to 2.4 kb (see Virus), and in the DI panels are distinguished
from defective RNAs by a vertical arrow (2). The smaller bands in segment 3 of DI EQV (A) and segment 7 of DI WSN (B) are the same size
as primer dimers. M, marker.
TABLE 1
Terminal Sequences Used to Prime RT-PCR
of WSN and EQV vRNAsa
Virus strain,
RNA segment,
and protein
encoded
Primer sequence for
first strand synthesis:
AGCAAAAGCAGG 1
the following
sequence
Primer sequence for
reverse synthesis:
AGTAGAAACAAGG
1 the following
sequence
EQV, 1, PB2 TCAAATATATTCA TCGTTTTTAAAC
WSN, 1, PB2 TCAATTATATTCA TCGTTTTTAAAC
EQV, 2, PB1 CAAACTATTTGAA CATTTTTTCACG
WSN, 2, PB1 CAAACCATTTGAA CATTTTTTCATG
EQV, 3, PA TACTGATCCAAAA NNNTTTTTb
WSN, 3, PA TACTGATTCAAAA NNNTTTTTb
EQV, 4, HA GGATATTTCTGTC GTGTTTTTAACT
WSN, 4, HA GGAAAATAAAAAC NNNTTTTTb
EQV, 5, NP GTAGATAATCACT GTATTTTTCTTT
WSN, 5, NP GTAGATAATCACT GTATTTTTCTTT
EQV, 6, NA AGTTTAAAATGAA AGTTTTTTTCGT
WSN, 6, NA AGTTTAAATGAAT NNNTTTTTb
EQV, 7, M TAGATATTGAAAG TAGTTTTTTACT
WSN, 7, M TAGATATTGAAAG TAGTTTTTTACT
EQV, 8, NS GTGACAAAAACAT NNNTTTTTb
WSN, 8, NS GTGACAAAGACAT NNNTTTTTb
a Sequences of primers actually used in RT-PCR are underlined. EQV
sequences were used to prime WSN segments, except when WSN
sequences are underlined.
b UNI2B (Noble and Dimmock, 1995).
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2A) and 5–8 in DI WSN inocula (Fig. 2B), although genomic
segment 6 was reduced in the latter. The absence of the
larger full-length genomic segments is almost certainly due
to the short pulse of UV irradiation that was used to destroy
infectivity contained in these preparations, and no genomic
segments were visible in the iDI inocula that had been
given prolonged UV-irradiation (Fig. 2A). Defective RNAs
derived from segments 1–8 were amplified from the DI EQV
although those from defective EQV segments 7 and 8 gave
faint bands (Fig. 2A), whereas defective RNAs from DI WSN
were amplified from segments 1–6 (Fig. 2B). Defective DNA
bands ranged in size from approximately 250 to 600 bp. The
difference between DI EQV and iDI EQV was qualitative
and, after prolonged UV-irradiation, defective bands from
segments 1 and 2 only remained in the iDI virus (Fig. 2A).
The destruction of EQV-defective RNAs was consistent with
the concomitant loss of mouse-protecting activity observed
in Fig. 1, while the isolation of segment 1 and 2 defective
bands from iDI EQV suggests that they were present in the
original preparation in relatively greater concentrations
than those derived from the other segments. RT-PCR bands
from defective segments 1–6 of all UV-inactivated iDI WSN
preparations were reproducibly of lower intensity (Fig. 2B,
data not shown), but as this is not a quantitative procedure,
we do not know the extent of the reduction in defective
RNAs. RT-PCR of the lungs of mice infected with EQV
yielded EQV genomic segments but no defective EQV
RNAs, indicating that the latter, when isolated from mice
given DI EQV, were not artefactual (Figs. 2A and 2B).
Comparative analysis of defective RNAs isolated from
the lungs of mice protected from lethal influenza by
inoculation with DI WSN or DI EQV
Mice were protected from a lethal WSN or EQV influ-
enza infection by intranasal inoculation of DI virus as
described above (Fig. 1). When virus infectivity reached a
peak in the lungs (Day 2 p.i. for EQV and Day 5 p.i. for
WSN; data not shown), lungs were removed and RNA
extracted. This was adjusted to 1 mg/ml and RT-PCR
carried out. Five or six sets of data were analysed for
each of the experiments reported below. No cDNA bands
were amplified from RNA extracted from mock-infected
mouse lungs in any experiment (e.g., Figs. 3A-3C).
Mice inoculated with WSN, WSN 1 DI WSN, or WSN 1
iDI WSN (Fig. 3A). DNA bands corresponding to genomic
segments 1–8 of infectious WSN were amplified from all
groups of infected mice. Defective RNAs derived from
WSN segments 1, 2, and 3 (200–600 nts) were reproduc-
ibly detected in lungs of mice inoculated with WSN 1 DI
WSN, WSN 1 iDI WSN, or WSN alone. However only
mice inoculated with WSN 1 DI WSN survived the infec-
tion, suggesting that the DI RNAs present in DI WSN
were mouse-protecting because they were either quali-
tatively or quantitatively different from those present in
the infectious virus preparation. Faint bands, amplified
from defective RNAs derived from WSN segments 4–6,
were sometimes present in mice inoculated with WSN 1
iDI WSN but not from the other groups.
Mice inoculated with EQV, EQV 1 DI EQV, or EQV 1 iDI
EQV (Fig. 3B). DNA bands corresponding to all eight
genomic segments of infectious EQV were amplified from
all groups of infected mice. However those from mice given
EQV 1 DI EQV were more difficult to detect than in mice
given EQV or EQV 1 iDI EQV. Although the RT-PCR tech-
nique is not quantitative, this result is consistent with the
observed inhibition of virus multiplication in the lungs of
infected mice given DI EQV (Noble and Dimmock, 1994;
data not shown). Lungs of mice inoculated with EQV 1 DI
EQV contained defective EQV RNAs of 200–550 nts derived
from either segments 1–4 (as in Fig. 3B) or 1–6 (data not
shown), depending on the mouse analysed. However, the
lungs of mice inoculated with EQV or EQV 1 iDI EQV
contained very few detectable defective EQV RNAs. Protec-
tion from death correlated directly, therefore, with the pres-
ence of EQV-defective RNAs in the lung.
Mice inoculated with WSN, WSN 1 DI EQV, or WSN 1
iDI EQV (Fig. 3C). The EQV primers amplify not only
EQV-defective RNAs from all segments but also WSN
full-length and defective RNAs corresponding to seg-
ments 1–3, 5, 7, and 8. RNAs from WSN segments 4 and
6 are not amplified by these primers. Lungs of mice
inoculated with WSN by definition contain only WSN-
defective RNAs. Lungs of mice inoculated with either
WSN 1 DI EQV or WSN 1 iDI EQV contained defective
RNAs (200–600 nts) derived from segments 1–4 or from
segments 1–6 (as in Fig. 3C), depending on the mouse
analysed. The provenance and properties of these de-
fective RNAs were determined by further analysis (see
below). No reduction in intensity of RT-PCR bands in
mice given WSN 1 DI EQV is seen in Fig. 3C although
multiplication of WSN is inhibited under these conditions
(Noble and Dimmock, 1994).
Identification of the virus of origin of defective RNAs
isolated from the lungs of mice protected from a
lethal WSN infection by inoculation with DI EQV
DNAs from RT-PCR bands corresponding to defective
RNAs isolated from the lungs of the protected mice
inoculated with WSN 1 DI EQV (as shown in Fig. 1C)
were cloned into pBluescript. All clones obtained were
cut with PstI and HindIII, which excised defective DNAs
intact from the plasmid vector. Defective virus sequences
were then analysed using enzymes that restricted defec-
tive WSN DNA but not defective EQV DNA. For example,
NruI and EcoRI cut small fragments from the ends of
excised segment 1 defective WSN DNAs and reduced
them in size, while segment 1 defective EQV DNAs were
unaltered (Fig. 4). The identification of some RNAs was
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confirmed by sequencing. Table 2 summarises the re-
sults of an analysis of defective RNAs derived from
segments 1, 2, and 3. The majority of defective segments
1, 2, and 3 isolated from the lungs of mice, protected by
inoculation with WSN 1 EQV DI, were of EQV origin in
the proportions 53, 74, and 100%, respectively. In con-
trast, lungs of mice that had been inoculated with WSN
1 iDI EQV yielded a lower proportion of defective EQV
segments 1, 2, 3, and 4 (0, 35, 55, and 100%, respectively),
suggesting that fewer protective defective EQV RNAs
were present. Defective segment 4 DNAs were isolated
from lungs of mice given WSN 1 iDI EQV (Table 2) even
FIG. 3. RT-PCR products obtained from RNA extracted from the lungs of mice. (A) Mice inoculated with WSN, WSN 1 DI WSN, WSN 1 iDI WSN,
and PBS (mock). (B) Mice inoculated with EQV, EQV 1 DI EQV, EQV 1 iDI EQV, and PBS (mock). (C) Mice inoculated with WSN, WSN 1 DI EQV, WSN
1 iDI EQV, and PBS (mock). Mice inoculated with DI virus were protected from lethal infection as in Fig. 1. Representative mice were sacrificed at
the peak of lung virus titer (2 days p.i. for EQV, 5 days p.i. for WSN) and RNA extracted from their lungs. After normalisation, RNA was amplified by
RT-PCR using terminal 59 and 39 primers. In (A), we used WSN primers as described for Fig. 2B, and in (B) and (C), we used EQV primers as described
for Fig. 2A. RNA segment numbers are indicated at the top of each lane. Genomic length RNAs are visible (segment 8, 0.89 kb to segments 1 and
2, 2.4 kb) in all lanes except segments 4 and 6 in (C) because EQV primers do not detect these WSN RNAs. M, marker.
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though none could be detected in the iDI inoculum (Fig.
2A). Their identity was confirmed by sequence analysis.
Analysis of the sequence of defective RNAs isolated
from DI EQV inoculum and from lungs of mice
protected from a lethal WSN infection by inoculation
with DI EQV
EQV and WSN segment 1–3 defective RNAs, isolated
and RT-PCR amplified from the inoculum and from in-
fected mouse lungs as described above, were cloned
and sequenced. The analysis of 51 sequences (47 EQV
and 4 WSN) is shown in Table 3. Most sequences were
unique even though there were only one or two major
bands of DNA per segment on gel electrophoresis (e.g.,
Fig. 3C). The four WSN RNAs were isolated from mouse
lung: three originated from segment 1 and one from
segment 2. Only three defective EQV RNA sequences
were isolated from both the inoculum and the protected
mice, one from each of segments 1, 2, and 3 (Table 3).
All defective RNAs contained the expected central
deletion. All segment 3 defective RNAs examined had
only the central deletion. Of the others, 33% of EQV
segment 1 and 47% of EQV segment 2 defective RNAs
had a smaller second deletion of two or more nucleo-
tides. This type of defective RNA was evenly distributed
between the inoculum and the mouse lung-derived
RNAs, suggesting that it had arisen during generation
and passage in the embryonated egg and not during its
propagation by WSN in the mouse. This is supported by
the fact that the only two segment 1 and 2 RNAs found in
both the inoculum and the lung were double deleted. All
the second deletions in EQV-defective segment 1 RNAs
started from nucleotide 2197, whereas most of those
found in defective segment 2 RNAs started from nts
58–60. Two additional junction sites were found in seg-
ment 2 defective RNAs. There were two different dele-
tions at 2101 to 2111, and another RNA had the nts 61–94
and nts 2138–2050 transposed (Table 3). The latter sug-
gests that these two sequence blocks may have been in
close proximity in the native conformation, although a
FIG. 4. Identification of the virus strain from which defective RNAs originated. Defective segment 1 RNAs were isolated from the lungs of mice
protected from lethal WSN infection by DI EQV. RNAs isolated from the lungs of mice inoculated with WSN 1 DI EQV (A) or with WSN 1 iDI EQV (B)
at 4 days p.i. were RT-PCR-amplified using primers complementary to the first 25 nts of EQV, and DNAs obtained cloned into pBluescript. Clones were
restricted using PstI and HindIII to excise the defective DNA from pBluescript and then further restricted using NruI (cuts WSN segment 1 at nt 77)
and EcoRI (cuts WSN segment 1 at nt 2285). EQV DNA is not cut. A mixture of WSN (W) and EQV (E) DNAs were obtained in (A) but only WSN DNAs
in (B). M, marker. The identity of DNAs marked (*) was confirmed by sequence analysis.
TABLE 2
Proportion of EQV- and WSN-Defective RNAs in a Population Iso-
lated from the Lungs of Mice Inoculated with WSN 1 DI EQV or
WSN 1 iDI EQVa
WSN-infected
mice also
inoculated with: Segment
Virus from
which defective
genomes
originated Percentage of
defective EQV RNA
(EQV/EQV 1 WSN)EQV WSN
DI EQV 1 9 (9) 8 (3) 53
2 17 (8) 6 (1) 74
3 18 (9) 0 100
iDI EQV 1 0 18 0
2 7 13 35
3 11 9 55
4 7 0 100
a Determined by restriction enzyme analysis; the origin of some
RNAs (in parenthesis) was confirmed by sequence analysis. iDI, DI
virus that had been given prolonged UV-irradiation so that it no longer
protected WSN-infected mice.
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TABLE 3
Analysis of the Nucleotide Sequences of Defective RNAs Isolated from DI EQV Inoculum or from Lungs
of Mice Protected from a Lethal WSN Infection by Inoculation with DI EQVa
Virus
No of
nts.
Main
deletion
No.
isolated Comments
Segment 1 (2341 nts)
Defective RNAs isolated from WSN 1 DI EQV inoculum
EQV 291 112–2162 1
318 96–2119 1
364 117–2086 1 Additional 8 nt D 2197–2204
372 150–2119 2 1 nt change in 1 DNA at 2264; 1 nt D in the other at 4
391 139–2089 1
436b 225–2121 3 Additional 9 nt D 2197–2205
Defective RNAs isolated from lungs of mice inoculated
with WSN 1 DI EQV
EQV 346 144–2139 1
418 172–2095 2 1 nt change in each at 87, 145
436b 225–2121 1 Additional 9 nt D 2197–2205
445 225–2121 1 1 nt change at 104
446 199–2086 1 Additional 8 nt D 2197–2204; 2 nt changes at 144,
2145
WSN 360 169–2150 2 1 nt change in 1 DNA at 2235
615 269–1974 1 Additional 21 nt D 2138–2158; 2 nt changes at
1990, 2036
Segment 2 (2341 nts)
Defective RNAs isolated from WSN 1 DI EQV inoculum
EQV 322 144–2163 1
329b 145–2153 1 Additional 4 nt D 60–63
331 128–2138 1 Additional 6 nt D 59–64
339 47–2049 1
354 110–2097 1
373 193–2161 1 1 nt change at 172
385 94–2050 1 1–60; 2050–2138; 61–94; 2137–2341c
410 196–2127 1 2 nt changes at 43, 183
455 201–2087 1
461 211–2091 1
470 211–2078 1 Additional 4 nt D 2108–2111; 1 nt change at 2275
Defective RNAs isolated from lungs of mice inoculated
with WSN 1 DI EQV
EQV 329b 145–2153 2 Additional 4 nt D 60–63
362 120–2099 1
397 151–2095 2
435 245–2112 1 Additional 39 nt D 58–96; 1 nt change at 23
436 211–2114 1 Additional 2 nt D 59–60; 2 nt change at 88, 2180
535 211–2010 1 Additional 7 nt D 2101–2107
WSN 250 25–2116 1 2 nt changes at 2114, 2305
Segment 3 (2233 nts)
Defective RNAs isolated from WSN 1 DI EQV inoculum
EQV 462 186–1957 2 1 nt change in 1 DNA at 2101
478b 183–1938 1
495 220–1958 1 1 nt change at 2187
Defective RNAs isolated from lungs of mice inoculated
with WSN 1 DI EQV
EQV 441 166–1988 2 nts 168–198 of EQV segment 1 present at junction
of both; 1 nt change in 1 DNA at 2015
478b 183–1938 2
484 191–1940 2 1 nt change in DNA at 2114
503 208–1938 1 1 nt change at 1995
540 220–1912 1 1 nt change at 1923
547 233–1918 1 1 nt D at 12; 2 nt changes at 1923, 1932
a Numbering of nucleotides relates to virion RNA and 39 to 59 orientation.
b Defective RNA that was present in both the DI virus preparation and infected mouse lung.
c An RNA where 39 and 59 sequence blocks have been exchanged.
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recent study of RNP cores does not support this idea
(Klumpp et al., 1997). Most (45/51) of the EQV- and WSN-
defective RNAs from segments 1 to 3 possessed at least
the 59 terminal 178 nts of virion RNA. The only exceptions
were six RNAs from segment 1 that had a short deletion
of eight or nine nucleotides at nts 136–144 from the 59
end of vRNA. Thus the defective RNAs analysed here
show evidence of nonrandom deletions that have not
been detected before (Jennings et al., 1983).
The absence of detectable infectivity in the EQV DI
inoculum by plaque assay (#10 PFU/ml) and the absence
of detectable EQV genomic segments 4 and 6 in pro-
tected mice (Fig. 3C) indicates that no infectious EQV
was present and therefore that the defective EQV RNAs
could not have been derived de novo in the mice. Thus
the EQV-defective RNAs described above originated
from the inoculum and were propagated by WSN in
mouse lung. One, some, or all them are therefore likely to
have been responsible for protection against infection
and disease.
DISCUSSION
This report considers the nature of defective RNAs in
the protection of mice from otherwise lethal influenza
virus infections. As well as its potential as an antiviral
measure, the heterologous protection afforded by DI
EQV (H3N8) to mice with an otherwise lethal WSN
(H1N1) infection allowed defective RNAs that originated
in the DI virus and were stably replicated in the lung to
be distinguished from those that accompanied the infec-
tious virus or were generated de novo. Thus the discus-
sion concentrates on heterologous protection.
Possible significance of sequence in the selection of
defective RNAs in mouse lung
The marked selection of defective RNAs from seg-
ments 1 to 3 in the lungs of mice inoculated with WSN 1
DI WSN (Results; Noble and Dimmock, 1995) was not
seen in mice inoculated with WSN 1 DI EQV or EQV 1
DI EQV. In the latter two, defective segment 4 RNAs and
sometimes defective segment 5 and 6 RNAs were de-
tected despite, in the case of the WSN 1 DI EQV group,
the absence of detectable replicating EQV. Thus survival
of defective EQV segments 4, 5, and 6 is not dependent
on the presence of EQV. EQV segment 4 defective RNAs
were also seen in mice given WSN 1 iDI EQV (Table 2
and confirmed by sequencing), even though they were
not detected in the iDI inoculum (Fig. 2A). EQV segment
4 defective RNAs were thus amplified readily by WSN,
whereas WSN-defective segment 4 RNAs were not am-
plified even when mice were inoculated with WSN plus a
10,000-fold excess of DI WSN (Fig. 3; Noble and Dim-
mock, 1995). It is possible that a bias was introduced into
the amplification of segment 4 by the use of the shorter
WSN reverse primer (Table 1), but this was not a factor in
the detection of segment 5.
The above data suggest that there was a positive
selection of EQV, but not WSN, segment 4, 5, and 6
defective RNAs and that this result is influenced by the
defective RNA population itself, the host (as WSN-defec-
tive segments 1–6 are replicated by WSN in chicken
embryos) and the infectious virus. This difference is
paralleled by different mechanisms of protection, as DI
EQV reduces the multiplication of both infectious EQV
and WSN in lungs, whereas DI WSN prevents WSN-
induced enhancement of the influx of T cells into the
lungs (Dimmock et al., 1986; McLain and Dimmock, 1989,
1991; McLain et al., 1992; Morgan and Dimmock, 1992;
Morgan et al., 1993; Noble and Dimmock, 1994).
Comparison of defective RNAs isolated from the DI
EQV inoculum and from lungs of mice protected from
lethal WSN infection by DI EQV
The inoculum is composed of 10,000 haemagglutinat-
ing units (HAU)/ml of noninfectious EQV DI or iDI and 1
HAU/ml infectious WSN. As expected, the small amount
of defective WSN RNA present in inoculum was not
detected by RT-PCR and sequencing. Because no infec-
tious EQV is present, EQV-defective RNAs can only be
replicated in the mouse by the infectious WSN, and
because the EQV RNAs cannot be generated de novo in
the mouse, they must have been selected from the inoc-
ulum population. WSN-defective RNAs were detected in
mouse lung and may have been amplified from those
unavoidably present in the infectious inoculum or gen-
erated de novo. They are evidently not relevant to pro-
tection as mice given infectious WSN virus alone do not
survive.
Sequence analysis of centrally deleted defective RNAs
isolated from the DI EQV inoculum and from the lungs of
mice inoculated with the same DI EQV showed that a
number of otherwise identical defective RNAs had minor
changes (nucleotide substitutions, one or two nucleotide
deletions) compared with the parent sequence. Because
of this, all such defective RNAs were included in our
analysis. Jennings et al. (1983) noted similar minor
changes in defective RNAs of A/PR/8/34 (H1N1). Overall
29% of DI inoculum RNAs in our study contained such
minor changes compared with 52% of RNAs isolated
from mouse lungs. RT-PCR is known to generate point
mutations, and these occur usually at a constant rate for
a particular sequence under the same conditions. In our
study, segment 1 defective RNAs differed, with 22% from
the inoculum and 67% from the lung showing minor
mutations (Table 4). The latter are therefore likely to have
arisen during replication of defective EQV by infectious
WSN in the lung rather than being generated by RT-PCR.
There is a great variety in the number of nucleotides
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derived from the 59 and 39 terminal portions of the
parental RNA segment that make up the EQV-defective
RNAs, especially in segment 2. However, the junction
sites are generally further from the 59 or 39 terminus in
the EQV mouse lung defective RNAs than in the EQV
inoculum defective RNAs. For example, segment 1
inoculum RNAs ranged from 96 to 225 nts at the 39 end
compared with 144–225 nts for those isolated from
mouse lung (Table 3 and Fig. 5). This difference be-
tween inoculum and mouse lung defective RNA pop-
ulations suggests some selection may be occurring in
the lung, and this is apparent in the 39 and 59 ends of
defective EQV segment 1 and 2 RNAs. No such differ-
ence was apparent with segment 3 defective RNAs
isolated from the inoculum, but the number isolated
(n 5 4) was very low.
The greater quantity of RT-PCR products in inoculum
EQV DI virus compared with iDI virus (Fig. 2A), together
with the greater percentage of EQV-defective RNAs iso-
lated from the lungs of DI virus-protected mice compared
with the group receiving iDI (Table 2), suggest that pro-
tection is indeed due to the effects of the defective RNAs.
In comparing individual segments isolated by RT-PCR,
some bias in the RT-PCR due to differences in the ter-
minal sequences of EQV and WSN sequences (Table 1)
cannot be ruled out. Sensitivity studies show, however,
that segment 1, 2, and 3 primers used for sequencing are
equivalent at the annealing temperature chosen (data
not shown) and are unlikely, therefore, to account for the
differences observed.
Sequence analysis of defective RNA isolated from the
DI EQV inoculum and from lungs of mice protected
from a lethal WSN infection
Generation of deletions and changes in defective EQV
RNAs. Previously, Jennings et al. (1983) analysed 35 PR8-
defective RNAs from infected eggs and six other PR8-
defective RNAs isolated by others (Moss and Brownlee,
1981; Winter et al., 1981; Fields and Winter, 1982; Nayak et
al., 1982; Sivasabramanian and Nayak, 1983), making a total
of 41 RNAs originating from all segments except segment 7,
although most (24/41) were derived from segment 1. Here,
51 defective RNAs (47 EQV and 4 WSN), from segments 1 to
3, were isolated from eggs and infected mouse lungs, the
majority being from EQV (subtype H3N8) that has not been
studied before.
Both studies detected minor sequence changes in
defective RNAs, and these may have resulted from drift
because of the lower selection pressure on defective
RNAs (Winter et al., 1981). However, the level of 5%
reported by Jennings et al. (1983) contrasts with the
22–67% found here. This may be because different vi-
ruses were used, the different host, and/or the replica-
tion of EQV RNAs by a heterologous virus (WSN).
The data from restriction digests (Fig. 4 and Table 2)
carried out on EQV- and WSN-defective RNAs extracted
from mice inoculated with DI EQV 1 WSN or iDI EQV 1
WSN suggest that segment 3 defective EQV RNAs out-
competed their WSN counterparts. Segment 2 defective
RNAs competed less well, and segment 1 defective
RNAs competed least well, despite all three segments
being subject to the same 10,000-fold excess of defective
RNA in the protected group. A comparison of segment 3
inoculum and mouse lung defective RNA populations
FIG. 5. Frequency distribution of 39 and 59 junction points for EQV
segment 1–3 vRNAs. The positions of the junctions of RNAs from Table
3 are shown relative to the 39 or 59 end of virion RNA. RNAs isolated
from the inoculum (f) and from mouse lung (u) are indicated. Full-
length segment 1 and 2 comprise 2431 nts and segment 3 comprises
2233 nts.
TABLE 4
Frequency of Minor Changes in the Sequences of Defective RNAs
Isolated from DI EQV Inoculum or from Lungs of Mice Protected from
an Otherwise Lethal WSN Infection by Inoculation with DI EQVa
Segment
No. of
RNAs
isolatedb
No. of RNAs
isolated with
minor changes
Percent of
defective RNAs
containing minor
changes
Defective RNAs isolated from WSN 1 DI EQV inoculum
1 9 2 22
2 11 3 27
3 4 2 50
Defective RNAs isolated from mice inoculated with WSN 1 DI EQV
1 9 (6) 6 (4) 67 (67)
2 9 (8) 3 (2) 33 (25)
3 9 5 56
a Minor changed include single nucleotide changes and one or two
nucleotide deletions.
b Mainly defective EQV RNAs with four WSN defective RNAs. Where
both were isolated, EQV RNAs are shown in parenthesis.
249DEFECTIVE INFLUENZA RNAs FROM MOUSE LUNG
revealed little divergence in terms of minor changes or
the proportion of the 59 and 39 ends of genomic molecule
that contribute to making the defective RNA, whereas the
two segment 1 populations showed the most differences
(Tables 3 and 4 and Fig. 5). This suggests that WSN
replicates segment 1 defective EQV RNAs less efficiently
than segment 3 EQV-defective RNAs. A nonrandom re-
assortment of virion RNA segments or generation of
defective RNAs also suggests that not all influenza seg-
ments are equally compatible between different strains
(Lubeck et al., 1979; Odagiri and Tobita, 1990; Subbarao
et al., 1995).
Apart from the minor changes, there were also short
deletions (4–39 nts) in some defective RNAs. We isolated
15/51 such RNAs from segments 1 and 2, but none from
segment 3 (Table 3), a higher frequency than found by
others (5/41; Jennings et al., 1983). These changes may
take place in eggs after the central deletion has oc-
curred, since we isolated two segment 1 RNAs with an
identical central deletion, but only one of which con-
tained a second deletion (of 9 nts: Table 3).
All the short deletions in segment 1 defective RNAs have
a common 39 junction at nucleotide 2197 (vRNA), and most
of those deletions in segment 2 defective RNAs have a
common 39 junction at nts 58–60 (vRNA), but are heteroge-
neous at the 59 junction (Table 3). The segment 2 double
deletions particularly are suggestive of generation by a
detaching and reattaching (jumping) polymerase during
positive strand synthesis (proceeding 39 to 59) that has a
common start point and a heterogeneous 59 reattachment
point. Others have suggested that defective influenza RNAs
are generated during positive strand synthesis (Robertson
et al., 1981; Fields and Winter, 1982).
Two EQV-defective segment 3 RNAs possess a short
sequence from the 39 end of segment 1 EQV vRNA (nts
168–198, Table 3) at the central junction. Differences
from the WSN sequence mean that this insert must be
EQV in origin. Only one previous description of a defec-
tive RNA derived from two different segments exists and
this was also segment 3 with a short central insert from
the 39 end of segment 1 vRNA (Moss and Brownlee, 1981;
Fields and Winter, 1982; Jennings et al., 1983).
Studies of the generation of defective viral RNAs in
other (plant) systems (White and Morris, 1995) suggested
the presence of sequence identity and complementarity
in directing deletions. However, this was not borne out by
previous studies on influenza defective RNAs (Jennings
et al., 1983). Although in our study some of the central
deletions showed limited sequence identity, others did
not and no particular site seemed to be involved. The
short deletion site at nt 2197 on segment 1 does, how-
ever, show a sequence repeat (2191 -GCTAATGTGCTA-
ATT -2205), whereas the segment 2 short deletion site
does not (51 - CTTAAAGGTGCCAGCGC - 67). The exact
site at which the short deletions occurred was some-
times difficult to pinpoint and, if ambiguous, was as-
signed to the same start point as the longer deletions, all
of which were unambiguous.
Minimum 59 sequence of defective EQV vRNAs. Despite
the lack of a particular site for the central deletions, all but
two of our defective RNAs, derived from segments 1–3,
possessed at least 178 nts from the 59 end (vRNA) (Table 3),
as did two segment 4 and two segment 5 defective RNAs
(data not shown). The only two exceptions lacked 8 or 9 nts
at nt 2197. The 39 site of central deletions was also further
from the 39 end of the mouse lung RNAs than those isolated
from the inoculum (Fig. 5). Furthermore, a number of seg-
ment 1 central deletions arise between nts 200 and 225
from the 59 end (vRNA), a number of segment 2 central
deletions arise between nts 225 and 250 from the 59 end,
and a number of segment 3 central deletions arise between
nts 275 and 300 from the 59 end (Table 3). This can be seen
as a double peak in Fig. 5 and suggests that these se-
quences may be required in vivo, possibly for genetic sta-
bility. This requirement may be different for each segment.
The overall increase in size of mouse lung EQV-defective
RNAs compared with those in the inoculum contrasts with
a reduction in size of WSN-defective RNA on passage
found in cell culture (Janda et al., 1979; De and Nayak, 1980;
Sivasabramanian and Nayak, 1983). However, the latter
RNAs were not sequenced, and RNAs that had undergone
successive rounds of replication and packaging could not
be distinguished from newly synthesised RNAs.
Properties of defective RNAs involved in the
protection of mice from lethal influenza virus infection
The defective RNAs analysed above were isolated
from the lungs of protected mice and were therefore
likely to have been responsible for that protection. De-
fective RNAs from different segments were not equally
represented, e.g., EQV segment 1 defective RNAs were
present in protected, but not unprotected mice; and seg-
ment 4, 5, and 6 defective RNAs were present in DI
EQV-protected but not DI WSN-protected mice, regard-
less of the infecting virus being WSN or EQV. Future
design of protective DI virus preparations will need to
examine this question of segment of origin of constituent
defective RNAs. The need for a critical amount of defec-
tive RNA in the protective inoculum was also indicated in
this study, but more information is needed about the
relative amount of each type of defective RNA that is
required for protection. Defective RNAs isolated from
protected mice contained a greater proportion of internal
sequences than those isolated from the inoculum and,
further, as mentioned above, different segments ap-
peared to possess different proportions of the 59 end of
vRNA. This has not been observed before, and posses-
sion by RNAs of these sequences may enhance their
propagation in the mouse and thus their ability to inter-
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fere with virus replication in the mouse. It would be
interesting to know what role, if any, these sequences
have in a normal virus infection.
In summary, we have studied the RNAs present in
homologous or heterologous DI influenza virus prepara-
tions that, when administered intranasally, protect mice
from a lethal dose of WSN (H1N1) or EQV (H3N8) influ-
enza virus. Few defective RNAs were isolated from lungs
of mice given EQV or EQV 1 iDI EQV, while defective
RNAs from segments 1 to 6 (or on occasion only 1 to 4)
were present in lungs of mice given EQV 1 DI EQV. Thus
protection correlated with the presence of defective
RNAs. A detailed analysis of defective RNAs isolated
from the lungs of mice protected from a lethal WSN
infection by DI EQV showed that most were EQV in
origin. Thus as no infectious EQV was present, at least
some of the defective RNAs from the DI EQV inoculum
must have been replicated by WSN in mouse lung. Fur-
ther it appeared that WSN preferentially replicated de-
fective EQV RNAs from segments 3–6 as the equivalent
segments of defective WSN RNA were not isolated. Seg-
ment 1 and 2 RNAs were a mixture (53% of segment 1
and 74% of segment 2 were EQV). Of 17 different defec-
tive EQV segment 1–3 RNAs isolated from mouse lung,
all but 3 differed in sequence (i.e., the primary central
deletion) from 20 defective RNAs isolated from the inoc-
ulum. Their deletions had no common break point. Some
defective EQV and WSN RNAs (13/47) also had minor
deletions of two or more nts. All were derived from
segments 1 (n 5 5) and 2 (n 5 8). The minor segment 1
and 2 deletions had common 39 breakpoints at nt 2197
and nts 58–60 of vRNA, respectively, and were thought to
have arisen in the chicken embryo. Their 59 breakpoints
were heterogeneous, suggesting that the defective RNAs
were generated during positive strand synthesis. Two
cloned EQV-defective segment 3 RNAs were chimeras
containing a 30-nt insert from segment 1. All defective
RNAs possessed at least 178 nts from the 59 end of
vRNA, although two had an extra deletion of 8 or 9 nts
within this region. The actual amount of 59 sequence
present correlated with segment, suggesting that this is
the minimum required for RNA propagation in the chick
embryo and adult mouse lung. We are now investigating
the ability of defined defective RNAs, alone and in com-
bination, to protect against disease.
MATERIALS AND METHODS
Viruses, DI viruses, and cells
We used A/equine/Newmarket/A/7339/79 (EQV: H3N8)
and A/WSN (H1N1). Infectious viruses were adapted to
lethality in mice by passage in mice. Stocks were then
prepared by inoculation into the allantoic cavity of em-
bryonated eggs at a high dilution to minimize the gener-
ation/propagation of DI viruses and were assayed by
haemagglutination (HA) of chick red blood cells and by
plaque assay in MDCK cells. Whilst infectious WSN
preparations also contained defective segment 1, 2, and
3 RNAs, infectious EQV usually contained no detectable
defective RNAs (data not shown). DI virus was prepared
as described previously (Dimmock et al., 1986). Briefly,
non-mouse-adapted virus was passaged three times at
high multiplicity in eggs and then concentrated to 104
HAU/ml. DI virus was UV irradiated for 30 s to remove
residual infectivity (Dimmock et al., 1986). Inactivated
(non-interfering) DI virus (iDI) was prepared by UV-
treatment for 4 min (Noble and Dimmock, 1994). iDI virus
did not lose HA or neuraminidase activity and was used
as a control immunogen in mice.
Mice
C3H/He-mg (H-2k) mice were originally obtained from
Bantin and Kingman Ltd., Grimston, Aldborough, Hull,
and subsequently bred at Warwick University Animal
Facility. All experiments followed the guidelines laid
down by the UK Co-ordinating Committee for Cancer
Research. Mice were given a lethal dose of 10 LD50 of
WSN or EQV as described previously (Dimmock et al.,
1986). Briefly, 5-week-old mice of either sex were inocu-
lated intranasally under light ether anaesthesia with two
intranasal doses given 2 h apart. The first dose (20 ml)
contained PBS or DI virus (irradiated briefly to remove
infectivity) or iDI virus (irradiated for a prolonged period
to destroy interfering activity). The second dose (20 ml)
was PBS or the same DI preparation (104 HAU/ml) con-
taining infectious virus (approximately 1 HAU/ml). This
regimen was optimised to provide maximum protection
of mice (Dimmock et al., 1986). When required, mice
were killed by cervical dislocation, their lungs removed,
and RNA extracted immediately. Morbidity was assessed
twice daily as a measure of infection. Initially mice de-
veloped malaise, ruffled fur, inactivity, and respiratory
distress. Progress was signified by altered gait, hunched
posture, laterally constricted abdomen, and failure to
gain weight. Some also developed raˆles but this was not
always observed. The percentage morbidity was calcu-
lated from the numbers of mice that showed at least the
initial combination of clinical signs listed. Each group
contained eight mice, two of which were removed for
extraction of lung RNA at the time of maximum lung
infectivity titer (at 2 days p.i. for EQV-infected mice, and at
5 days p.i. for WSN-infected mice).
RNA extraction
Total cellular RNA was extracted (G. P. Thomas, per-
sonal communication) from each pair of mouse lungs by
homogenising in a pestle and mortar with sand (250 to
170 mesh, Sigma Chemical Co., Poole, Dorset) in the
presence of 4 M guanidium thiocyanate in 50 mM
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Tris.HCl (pH 7.6), 10 mM EDTA (pH 8), 2% N-lauroyl-
sarcosine, and 1% mercaptoethanol. Lysates were ex-
tracted in 50 ml polypropylene tubes at 60°C for 10 min
with one volume of phenol (pH 4.5), one volume of chlo-
roform, and two volumes of 0.1 M sodium acetate. Tubes
were chilled briefly on ice and centrifuged at 3000 rpm
for 10 min on a Beckman GPR centrifuge, before being
reextracted with phenol (pH 4.5) and chloroform at 60°C
for 10 min. Following chilling and centrifugation, RNA
was precipitated with two volumes of ethanol at 220°C.
Pellets were treated with 50 mg/ml proteinase K in 10 mM
Tris (pH 7.8), 5 mM EDTA (pH 8), 0.5% SDS at 37°C for 20
min, then reextracted twice with phenol (pH 4.5) and
chloroform at 60°C. Extracted RNA was precipitated with
0.1 M sodium acetate and 2.5 volumes of ethanol. RNA
was extracted from DI and inactivated DI virus inoculum
by the hot phenol method (Duhaut and McCauley, 1996).
RT-PCR
Primers complementary to the first 25 nucleotides of the
39 end of each segment of EQV influenza were used in first
strand DNA synthesis for all WSN and EQV segments,
except WSN segments 4 and 6. For these we used primers
complementary to their first 20 nucleotides (see Table 1), as
their sequences differed significantly from EQV. EQV prim-
ers were chosen to minimise cross-reactions noted earlier
(Noble and Dimmock, 1995). Primer pairs for WSN- and
EQV-defective RNA detected down to 104 molecules (10 fg)
for segment 1, and 105 molecules (100 fg) for segments 2
and 3, the major limiting factor in sensitivity being the RT
step. RNA was reverse transcribed in 20 ml reaction buffer
[50 mM Tris.HCl (pH 8.3), 75 mM KCl, 3 mM MgCl2, 10 mM
dithiothreitol (DTT), 1 mM of each dNTP, 10 U ribonuclease
inhibitor (Gibco BRL, Paisley), 13 U Moloney murine leukae-
mia virus reverse transcriptase (Gibco BRL), 200 pmoles
complementary primer] at 37°C for 60 min. Second strand
DNA synthesis of segments 3 and 8 of both strains (se-
quence of EQV strain used not available) and 4 and 6 of
WSN was primed by UNI2B, which is homologous to the 59
terminus of all eight vRNA segments. Segments 1, 2, 5, and
7 of both strains and 4 and 6 of EQV strains were amplified
using primers complementary to the first 25 nucleotides of
the 59 end of each segment of equine influenza (Table 1).
PCR was carried out in 20 mM Tris.HCl (pH 8.4), 50 mM KCl,
2 mM MgCl2, 0.2 mM of each dNTP, 2.5 U Taq DNA poly-
merase (Gibco BRL), 20 pmoles primer, and 20 ml first
strand synthesis and overlaid with paraffin. Reactions were
performed in a PCR block [Techne (Cambridge) Ltd.] for 30
cycles of 60 s at 94°C, 60 s at 55°, and 120 s at 72°C,
followed by a final cycle of 72°C for 5 min. The annealing
temperature chosen was below the Tm of all but the UNI2B
and the segment 6 forward primer. PCR products were
separated on 2% agarose gels alongside DNA markers
(Gibco-BRL).
Cloning and sequencing
RT-PCR products were purified from agarose gel slices
by electroelution into 10 mM Tris.HCl (pH 8) and 1 mM
EDTA (pH 8). Purified products were blunt-ended by
incubation with 4 U DNA polymerase I (large fragment),
50 mM Tris.HCl (pH 8), 7 mM MgCl2, 1 mM DTT, and 0.2
mM of each dNTP at 37°C for 30 min. DNA was then
cloned into the pBluescript vector (Stratagene) at the
EcoR V site. DI clones were separated from vector se-
quences by digestion with PstI and HindIII and identified
by further restriction analysis: for segment 1, NruI (cut
WSN at nt 77) and EcoRI (cut WSN at nt 2285); for
segment 2, BsmFI (cut WSN at nt 136) and EcoRV (cut
WSN at nt 2157); for segment 3, ClaI (cut WSN at nt 185)
and BsmFI (cut WSN at nt 2056 and nt 2073); for segment
4, AccI (cut EQV at nt 70) and BglI (cut EQV at nt 1696).
Sequencing was performed on a 373a automated DNA
sequencer (Perkin-Elmer Applied Biosystems). A total of
5 of 60 clones (8.3%) that comprised linear viral se-
quences or random fragments and may have been RT-
PCR or cloning artifacts were excluded from the analysis.
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